GlaxoSmithKline: Funding Open Innovation
The 4-Traders website reported that GlaxoSmithKline (GSK) has announced a funding injection of up to £5m from the Wellcome Trust to support its open approach to discovering and developing urgently needed new treatments for diseases of the developing world. The funding will move early-stage research to the next level, to find new medicines for diseases
Comments Off on GlaxoSmithKline: Funding Open Innovation • Read this story »
More Articles
Pharma Industry Continues Building Open Innovation Models
The Nature Biotechnology website reports that seven large pharma companies and a biotech firm, Alnylam, have formed a collaboration with the World Intellectual Property Organisation (WIPO) to establish WIPO Re:Search. This open innovation initiative lines up United Nations agency WIPO of Geneva with